Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pillar5 Pharma
Arnprior, Ontario, Canadapillar5pharma.com ↗
- Ownership
- Private
- Employees
- ~100
- Development stage
- Commercial
01
Overview
Pillar5 Pharma operates as a leading Canadian CDMO specializing in sterile ophthalmic manufacturing, particularly multi-dose preservative-free eye drop solutions. The company also manufactures oral solid dose pharmaceuticals for both branded and generic markets. Their facility has passed Health Canada and FDA inspections with no major findings.
- Modalities
- Small molecule (oral solid dose tablets/capsules)Sterile ophthalmic solutionsBiologic
- Industry
- Contract Manufacturing Organization
02
Partnerships
IntelGenx Corp. – contract manufacturing of CPI‑300 antidepressant tabletUVista – bottling partner for UVista SPF Eye Drops artificial tears product
Beyond the preview
Go deeper on Pillar5 Pharma.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pillar5 Pharma.